Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy

Sponsor
AC Camargo Cancer Center
Study ID
NCT07285356
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Surgical Gloves — DEVICE
    During each chemotherapy cycle, patients in the experimental group will wear compressive surgical gloves (one size smaller than recommended based on palmar surface measurement) on both hands, which will be put on 30 minutes before the infusion and remain in place until 30 minutes after the end of the chemotherapy infusion.

Study Details

The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.

Key Dates

First listed
Dec 16, 2025
Start date
Oct 6, 2025
Status verified
Dec 2025
Primary completion
Sep 18, 2026
Completion
Sep 18, 2026

Study Design

Enrollment
84 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Surgical Gloves
    During each chemotherapy cycle, patients in the experimental arm will wear compressive surgical gloves (0.5 size smaller than recommended based on palmar surface measurement) on both hands, which will be put on 30 minutes before the infusion and remain in place until 30 minutes after the end of the chemotherapy infusion.
  • No Intervention: No Surgical Gloves
    The control arm will receive treatment according to current recommendations without the use of any devices on the hands.

Primary Outcome Measure

Oxaliplatin-Induced Peripheral Neuropathy [ Time Frame: Baseline, 2 months, 4 months and 6 months ]

Central Contacts

Find similar trials

Nationwide
Colorectal cancer trialsOncology trialsGI oncology trials

Related Studies